# JMBI-001

Source: https://onco.cc/drugs/jmbi-001/  
OnCo record `jmbi-001` (Treatment). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

JMBI-001 is an experimental oral tablet from Anticancer Bioscience, in phase 1 trials for MYC-positive advanced solid tumours and relapsed or refractory non-Hodgkin lymphoma.

## Summary

JMBI-001 is an oral tablet (small molecule not stated) from Anticancer Bioscience, with Peking University Cancer Hospital & Institute as partner. Tested in adults with MYC-positive advanced cancers; the company describes its work as MYC synthetic lethality, but no source states JMBI-001's molecular target. Its furthest stage is phase 1, for MYC-positive advanced solid tumours and relapsed or refractory non-Hodgkin lymphoma. ClinicalTrials.gov registers it in one study linked below. Phase 1/2 recruiting, start October 2026 (NCT07864701). Whether it works in people has not been established unless a trial below reports it.

## Fields

- Kind: Treatment
- Status: phase-1
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Code: JMBI-001
- Modality: Oral tablet (small molecule not stated)
- Mechanism: Tested in adults with MYC-positive advanced cancers; the company describes its work as MYC synthetic lethality, but no source states JMBI-001's molecular target.

## Sources

- Anticancer Bioscience: clinicaltrials.gov: https://clinicaltrials.gov/study/NCT07864701
- Anticancer Bioscience: anticancerbio.com: https://www.anticancerbio.com/
- ClinicalTrials.gov: trials of JMBI-001: https://clinicaltrials.gov/search?intr=JMBI-001

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/), [Non-Hodgkin lymphoma (all types)](https://onco.cc/cancers/non-hodgkin-lymphoma/)
- companies: [Anticancer Bioscience](https://onco.cc/companies/anticancer-bioscience/)
- trials: [Study of JMBI-001 in Patients With MYC-Positive Advanced Cancers](https://onco.cc/trials/nct07864701/)

---
JSON: https://onco.cc/api/v1/entities/jmbi-001.json